spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  gene therapies 

 HSMN NewsFeed - 2 Mar 2026
Argo Biopharma Appoints Dr. Gena Wang as Chief Financial Officer and Chief Strategy Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Jan 2026
REGENXBIO Announces Regulatory Update on Ultra Rare MPS Programs
Regenerative Medicine FDA
 HSMN NewsFeed - 9 Dec 2025
Mercury Bio Announces Appointment of Casey Perkins as Vice President of Corporate Strategy & Business Development
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 15 Jul 2025
Tract Bio Appoints Chris Galloway, M.D., as Chief Medical and Development Officer and Expands Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jul 2025
Klotho Neurosciences, Inc. Granted FDA Orphan Drug Designation for KLTO-202 for Treatment of Amyotrophic Lateral Sclerosis ("ALS" or "Lou Gehrig's Disease")
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 24 Jun 2025
Ascidian Therapeutics Appoints Dr. Murray A. Abramson as Chief Development Officer and Establishes Ophthalmology Clinical Advisory Board to Advance ACDN-01 for Treatment of Stargardt Disease
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 11 Jun 2025
SpliceBio Secures $135 Million Series B Financing to Advance Lead Program SB-007 in Stargardt Disease and Expand Pipeline of Genetic Medicines
Regenerative Medicine Ophthalmology Venture Capital
 HSMN NewsFeed - 27 May 2025
BrainStorm Secures Key Manufacturing Partnership with Minaris for Upcoming NurOwn(R) Phase 3b ALS Clinical Trials
Regenerative Medicine Neurology
 HSMN NewsFeed - 7 May 2025
PAQ Therapeutics Appoints Andrew Krivoshik, MD, PhD, as Chief Medical Officer, Announces Addition of Eric Rubin, MD, and Piro Lito MD, PhD, to Advisory Board
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 25 Mar 2025
Hubble Therapeutics Closes Series A Financing to Develop Gene Therapy Cure for LCA16
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 9 Jan 2025
RheumaGen, Inc. Launches with $15 Million Series A Financing to Advance a New Class of HLA Gene-Editing Therapies for Major Autoimmune Diseases
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 Dec 2024
Astellas and Sangamo Therapeutics Announce Capsid License Agreement to Deliver Genomic Medicines for Neurological Diseases
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 30 Oct 2024
FDA Grants Orphan Drug Designation to Capsida Biotherapeutics for Potential Treatment of STXBP1 Developmental and Epileptic Encephalopathy
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 Sep 2024
Affinia Therapeutics Announces the Appointment of Rami Daoud as Chief Business and Financial Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 24 Jul 2024
Beacon Therapeutics Appoints Lance Baldo, MD as Chief Executive Officer and Thomas Biancardi as Chief Financial Officer
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 3 Jul 2024
Beacon Therapeutics Raises $170 Million in Series B Funding to Advance Development of Ophthalmic Gene Therapies
Regenerative Medicine Ophthalmology Venture Capital
 HSMN NewsFeed - 12 Jun 2024
REGENXBIO Announces Leadership Transition
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 May 2024
Nanoscope Therapeutics Appoints Khandan Baradaran as Senior Vice President of Regulatory and Quality
Regenerative Medicine Ophthalmology Personnel
 HSMN NewsFeed - 29 Apr 2024
Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia B
Biopharmaceuticals Diagnostics FDA
 HSMN NewsFeed - 25 Mar 2024
Poseida Therapeutics Appoints Syed Rizvi, M.D., as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 Nov 2023
Actinium Appoints Lynn Bodarky as Chief Business Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 7 Sep 2023
enGene Appoints Richard Bryce, MBChB, MRCGP, MFPM, as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Aug 2023
VintaBio Names Jennifer Kingsley Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jul 2023
Skyline Therapeutics Receives FDA Clearance of IND for SKG0106, a Novel Intravitreally Delivered AAV Gene Therapy Candidate for Neovascular Age-related Macular Degeneration
Regenerative Medicine Ophthalmology FDA
 HSMN NewsFeed - 8 Jun 2023
Kate Therapeutics Debuts With $51 Million Series A to Develop Next-Generation Genetic Medicines to Treat Muscle and Heart Diseases
Regenerative Medicine Venture Capital
 HSMN NewsFeed - 8 Jun 2023
Astellas and Kate Therapeutics Announce Exclusive License Agreement for KT430
Biopharmaceuticals Regenerative Medicine Licensing
 HSMN NewsFeed - 5 Jun 2023
Visgenx Appoints William Pedranti as Chief Executive Officer
Regenerative Medicine Ophthalmology Personnel
 HSMN NewsFeed - 7 Mar 2023
Capsida Biotherapeutics Appoints Susan Catalano, Ph.D. as Chief Scientific Officer
Biopharmaceuticals Regenerative Medicine Personnel
 HSMN NewsFeed - 3 Feb 2023
Treadwell Therapeutics Announces the Appointment of Roger Sidhu, M.D., as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 30 Jan 2023
Nanoscope Therapeutics Receives Fast Track Designation by the FDA for MCO-010 for the Treatment of Stargardt Disease
Regenerative Medicine Ophthalmology FDA
 HSMN NewsFeed - 20 Jan 2023
Astellas Announces Hold Lifted by FDA on FORTIS Clinical Trial of AT845 Investigational Treatment for Adult Patients with Late-Onset Pompe Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Jan 2023
Perceive Biotherapeutics Attracts $78M Series B Financing to Advance Diversified Pipeline
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 14 Jun 2022
Anjarium Biosciences appoints Stephen Yoo, MD as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Jun 2022
STRM.BIO Appoints Vanessa Salazar as Vice President of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 May 2022
Odyssey Therapeutics Appoints Darryl Patrick, D.V.M., Ph.D., as Executive Vice President of Non-Clinical Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 10 May 2022
Genascence Announces First Close in Series A Financing led by Pacira BioSciences and Expands Board of Directors and Scientific Advisory Board
Regenerative Medicine Orthopaedic Venture Capital
 HSMN NewsFeed - 18 Apr 2022
Nanoscope Therapeutics Appoints Pharma Industry Veteran Aaron Osborne, MBBS, as Chief Medical Officer and Chief Development Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Jan 2022
Nanoscope Therapeutics Announces FDA Clearance of IND for MCO-010 Gene Therapy in Stargardt Macular Degeneration Patients
Regenerative Medicine Ophthalmology FDA
 HSMN NewsFeed - 12 Nov 2021
Johnson & Johnson Announces Plans to Accelerate Innovation, Serve Patients and Consumers, and Unlock Value through Intent to Separate Consumer Health Business
Devices Biopharmaceuticals
 HSMN NewsFeed - 28 Oct 2021
Inhibrx Strengthens Leadership Team with Three Key Executive Hires and Announces Appointment of Kristiina Vuori, M.D., Ph.D. to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Oct 2021
Poseida Therapeutics Announces Leadership Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Sep 2021
DiNAQOR Appoints Medical Device Leader Mark Dehdashtian to Oversee New U.S.-Based Division, Device Development and Production
Devices Personnel
 HSMN NewsFeed - 13 Sep 2021
ViaCyte Appoints Stem Cell Therapy Expert Dr. Timothy Kieffer as Chief Scientific Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 9 Sep 2021
Obsidian Therapeutics Announces Closing of $115 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 28 Jul 2021
Ring Therapeutics Raises $117 Million in Series B Funding to Expand Novel Vector Platform to Unlock the Full Potential of Gene Therapy
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 21 Jul 2021
Coave Therapeutics Closes €33 million ($39 million) Series B Financing to Develop its Gene Therapy Pipeline and Next-Generation Vectors based on its AAV-Ligand Conjugate Platform
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 5 Jul 2021
Transine Therapeutics Appoints Industry Veteran Jan Thirkettle Ph.D. as CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Jun 2021
Nuevocor closes US$24M Series A Financing to Advance Novel Gene Therapies for Cardiomyopathies
Biopharmaceuticals Cardiology Venture Capital
 HSMN NewsFeed - 18 May 2021
Vedere Bio II Launches with $77 Million Series A Financing to Develop Next Generation Ocular Gene Therapies
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 29 Apr 2021
Capsida Biotherapeutics Debuts with $140 Million of Capital
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 23 Mar 2021
Poseida Therapeutics Announces Carl June, M.D., to Chair Immuno-Oncology Scientific Advisory Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Mar 2021
BioMarin Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to Valoctocogene Roxaparvovec, Investigational Gene Therapy for Hemophilia A
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Dec 2020
Lilly Announces Agreement to Acquire Prevail Therapeutics
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 2 Nov 2020
Corlieve Therapeutics SAS Closes Seed Financing to Develop Therapies for Severe Neurological Conditions
Regenerative Medicine Neurology Venture Capital
 HSMN NewsFeed - 2 Oct 2020
BioMarin, Pioneer in Phenylketonuria (PKU) and Gene Therapy, Receives FDA Fast Track Designation for PKU Investigational Gene Therapy, BMN 307
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Sep 2020
Obsidian Therapeutics Appoints Rob Ross, M.D., to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Aug 2020
StrideBio Expands Leadership Team with Appointment of William Monteith as Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jul 2020
APEIRON Biologics and MaxCyte Enter into Clinical and Commercial Licensing Agreement for APN401
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 2 Jul 2020
Hansa Biopharma Announces Exclusive Agreement With Sarepta Therapeutics to Develop and Promote Imlifidase as Pre-treatment Ahead of Gene Therapy in Select Indications
Biopharmaceuticals Licensing
 HSMN NewsFeed - 1 Jun 2020
SwanBio Therapeutics Appoints Steven Zelenkofske, DO, as Chief Medical Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 12 May 2020
Kriya Therapeutics announces $80 million Series A financing to advance gene therapies for highly prevalent serious diseases
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 7 May 2020
Caribou Biosciences and MaxCyte Enter into Clinical and Commercial License Agreement
Biopharmaceuticals Licensing
 HSMN NewsFeed - 27 Apr 2020
JCR Pharmaceuticals announces Completion of Acquisition of ArmaGen, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 23 Apr 2020
SwanBio Therapeutics Announces Series A Expansion to Fund its Lead Program and Grow Pipeline in Gene Therapy for Neurological Diseases
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 11 Feb 2020
Encoded Therapeutics Expands Gene Therapy Leadership with Key Appointment and Promotion
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jan 2020
enGene Announces Additions to Senior Management Team
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 8 Jan 2020
Aruvant Receives FDA Rare Pediatric Disease Designation for ARU-1801 for the Treatment of Sickle Cell Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 Jan 2020
CARsgen Appoints Yong Fan as Senior Vice President of Global Regulatory Affairs
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 18 Dec 2019
Encoded Therapeutics Strengthens Senior Leadership Team with Key Appointments in Regulatory and Human Resources Functions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Oct 2019
Anixa Biosciences Names Novartis Executive Dr. Emanuele Ostuni to Scientific Advisory Board
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 21 Oct 2019
SmartPharm Therapeutics Appoints John T. Potts, MD, DSc, to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Sep 2019
AskBio Acquires Assets from RoverMed BioSciences, Adds Nanotechnology Precision to Delivery of AAV Gene Therapeutics
Biopharmaceuticals Drug Delivery Acquisitions
 HSMN NewsFeed - 17 Sep 2019
Encoded Therapeutics Expands Leadership Team with Key Appointments, Adding Expertise in Manufacturing and Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Sep 2019
REGENXBIO Announces Exclusive Worldwide Option and License Agreement with Clearside Biomedical for Evaluation of In-Office Delivery Platform for RGX-314
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 31 Jul 2019
REGENXBIO Announces New License Agreement with Pfizer for the Treatment of Friedreich's Ataxia Using NAV(R) AAV9 Vector
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 25 Jul 2019
Obsidian Therapeutics Announces Strengthening of Executive Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Jun 2019
Encoded Therapeutics, Inc. Announces $104 Million Series C Financing to Advance Lead Gene Therapy Program in Dravet Syndrome and Unveils its Precision Gene Therapy Platform
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 25 Jun 2019
SmartPharm Therapeutics Appoints José Trevejo, MD, PhD, as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jun 2019
BioEclipse Therapeutics(TM) Announces Appointment of New Directors and Series A-1 Financing
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 31 May 2019
Iovance Biotherapeutics Expands Partnership with WuXi Advanced Therapies Business
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 Apr 2019
Catalent to acquire gene therapy leader Paragon Bioservices, Inc. for $1.2 billion
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 25 Feb 2019
Gracell Biotechnologies Completes $85 Million Series B for Immune Cell Gene Therapies
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 8 Jan 2019
Cellenkos, Inc. Appoints Elizabeth Read as Chief Technology Officer, Adding Technology and Regulatory Affairs Expertise to its Executive Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Dec 2018
GenEdit Closes $8.5 million Series Seed Financing
Regenerative Medicine Venture Capital Personnel
 HSMN NewsFeed - 26 Nov 2018
BlueRock Therapeutics Appoints Min Wang, J.D., Ph.D., as Chief Legal and Administrative Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 14 Nov 2018
Precision BioSciences and MaxCyte Enter into Clinical and Commercial License Agreement
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 18 Jul 2018
Cook(R) Regentec Announces First U.S. Clinical Use of Advance(R) CS Coronary Sinus Infusion Catheter to Deliver a Therapeutic in Heart Failure Patients
Devices Drug Delivery Cardiology
 HSMN NewsFeed - 16 Jul 2018
enGene Appoints Veteran Life Sciences Executive Jason D. Hanson as Chief Executive Officer and President
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 13 Jun 2018
StrideBio Closes $15.7 Million Series A Financing to Advance Transformational AAV Platform
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 12 Jun 2018
Artelo Biosciences Enters Into Global R&D Partnership With Syngene International And Aptus Clinical For The Clinical Development Of ART27.13 In Oncology
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Apr 2018
Abeona Therapeutics Appoints Carsten Thiel, Ph.D., as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Feb 2018
Poseida Therapeutics Appoints Mark Gergen as Chief Business Officer and Chief Financial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 27 Feb 2018
Senti Biosciences Secures $53 Million Series A to Build the Future of Gene and Cell-Based Therapies
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 12 Dec 2017
Eyevensys Appoints Dr. Patricia Zilliox as Chief Executive Officer
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 16 Nov 2017
FDA Announces Comprehensive Regenerative Medicine Policy Framework
Regenerative Medicine FDA
 HSMN NewsFeed - 28 Aug 2017
CSL Behring to Acquire Biotech Company Calimmune and its Proprietary Stem Cell Gene Therapy Platform
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 11 Jul 2017
Nuredis Appoints Julie Anne Smith as Chief Executive Officer to Lead Neurodegenerative Disease Company
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 24 Apr 2017
Mustang Bio Announces Appointment of Manuel Litchman, M.D., as President and Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 10 Apr 2017
Vericel Announces Appointment of Michael Halpin as Senior Vice President, Quality and Regulatory Affairs
Regenerative Medicine Personnel
 HSMN NewsFeed - 27 Feb 2017
BrainStorm Names Dr. June S. Almenoff and Arturo O. Araya to its Board of Directors as Company Prepares for Clinical and Commercial Success
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 21 Feb 2017
BrainStorm Seeking Approval To Distribute NurOwn(R) in Canada
Regenerative Medicine Neurology Regulatory Distribution
 HSMN NewsFeed - 12 Dec 2016
Bayer and Versant Ventures Join Forces to Launch Stem Cell Therapy Company BlueRock Therapeutics with USD 225 Million Series A Financing
Regenerative Medicine Venture Capital
 HSMN NewsFeed - 18 Nov 2016
AGTC Appoints Michael Goldstein, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Jun 2016
Homology Medicines Appoints James Warren, Ph.D. as Vice President of Manufacturing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 May 2016
Investigational Gene-Based Therapy for Alpha-1 Antitrypsin (AAT) Deficiency Demonstrates Durable Response at Five Years
Biopharmaceuticals
 HSMN NewsFeed - 8 Feb 2016
Global Blood Therapeutics Announces Changes to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Nov 2015
Calimmune Expands Board of Directors, Names R. Scott Greer as Chairman
Biopharmaceuticals HIV/AIDS Personnel
 HSMN NewsFeed - 12 Nov 2015
RetroSense Therapeutics Raises $6 million in an Over-Subscribed Series B Financing to Advance Clinical Development of Lead Product RST-001 for Retinitis Pigmentosa
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 3 Nov 2015
Solid GT Raises $42.5 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 29 Oct 2015
Bellicum Appoints Alan K. Smith as Senior Vice President of Manufacturing
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 10 Sep 2015
Agilis Biotherapeutics Appoints Arthur Tzianabos, Ph.D., to the Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 8 Sep 2015
Selecta Announces $38 Million Series E Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 22 Jul 2015
Voyager Therapeutics Appoints Michael Higgins to Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 1 Jun 2015
POZEN Announces Retirement of Founder, Chairman and CEO Dr. John R. Plachetka; Adrian Adams Named as CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Sep 2014
Dimension Therapeutics Names Annalisa Jenkins as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Oct 2013
Celladon Corporation Appoints Michael Narachi as Chairman of the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Aug 2013
Sangamo BioSciences to Acquire Ceregene
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 7 Jan 2013
Celator(R) Pharmaceuticals Announces Appointment of Lisa DeLuca as Vice President, Regulatory Affairs
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 2 Nov 2012
uniQure's Glybera(R) First Gene Therapy Approved by European Commission
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 19 Apr 2012
RetroSense Welcomes Dr. Peter Francis as Clinical Director
Regenerative Medicine Ophthalmology Personnel
 HSMN NewsFeed - 8 Dec 2011
Auxilium Pharmaceuticals, Inc. Appoints Adrian Adams Chief Executive Officer and President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Sep 2011
Neurologix Appoints Adrian Adams as Company Chairman and Chief Executive Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 31 Jan 2011
Cook Pharmica Adds E. Morrey Atkinson, Ph.D., to Leadership Team as Vice President of Research and Development, Chief Scientific Officer
Devices Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jun 2009
BioSante Pharmaceuticals and Cell Genesys Sign Definitive Merger Agreement
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 3 Sep 2008
Neurologix Licenses Exclusive Rights to Key Gene from Aegera Therapeutics for Use as a Potential Gene Therapy for Huntington's Disease
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 22 Jul 2008
Final Results From Phase 2 Clinical Trial of GVAX Immunotherapy for Prostate Cancer Published in the American Cancer Society's Journal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 Feb 2008
Cook Pharmica Names Fred Larimore, Ph.D., Vice President of Scientific Affairs, CSO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Jan 2008
VIRxSYS and Lentigen Announce Litigation Settlement
Biopharmaceuticals Litigation
 HSMN NewsFeed - 13 Dec 2007
Neurologix Gene Therapy Approach to Parkinson's Disease Granted Fast Track Designation From FDA
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 19 Nov 2007
Cook Pharmica Signs Agreement with Inspiration Biopharmaceuticals for the Transfer of its Clinical Manufacturing Process for Lead Hemophilia Compound
Biopharmaceuticals
 HSMN NewsFeed - 10 Sep 2007
BrainStorm Cell Therapeutics Takes Initial Steps Toward FDA Submission
Regenerative Medicine Neurology
 HSMN NewsFeed - 21 Aug 2007
Inovio Biomedical Appoints Dr. Michael Fons as Vice President, Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Jun 2007
Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinson's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 21 Jun 2007
Ceregene and Genzyme Announce Partnership for the Development and Commercialization of Cere-120 for Parkinson's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 17 May 2007
Celladon and Targeted Genetics Initiate Phase I Clinical Trial of MYDICAR(TM) in Patients With Heart Failure
Regenerative Medicine Cardiology
 HSMN NewsFeed - 9 May 2007
Dendreon Receives Complete Response Letter From FDA for Provenge(R) Biologics License Application
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 2 May 2007
Ceregene Presents Interim Phase 1 Clinical Data of CERE-110 for the Treatment of Alzheimer's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 13 Apr 2007
Ceregene Enrolling Patients for Phase 2 Clinical Trial of Parkinson's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 20 Mar 2007
Cordis Corporation to Emphasize Commitment to Interventional Cardiology at ACC.07
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Jan 2007
Cell Genesys Announces Encouraging Follow-Up Survival Data From Phase 2 Clinical Trial of GVAX(R) Immunotherapy for Pancreatic Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Nov 2006
Cell Genesys Announces Management Change
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 31 Oct 2006
Pluristem Expects to Submit Pre-IND Document to FDA by End of 2006
Regenerative Medicine
Return to NewsFeed  

 Additional items found! 70

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 70 additional stories matching:
gene therapies
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!